Isaev Nickolay K, Genrikhs Elizaveta E, Stelmashook Elena V
Research Center of Neurology, 125367 Moscow, Russia.
Biological Faculty, M.V. Lomonosov Moscow State University, 119991 Moscow, Russia.
Antioxidants (Basel). 2023 Feb 9;12(2):433. doi: 10.3390/antiox12020433.
Oxidative stress is one of the main pathogenic factors of neuron damage in neurodegenerative processes; this makes it an important therapeutic target to which the action of neuroprotectors should be directed. One of these drugs is thymoquinone. According to modern data, this substance has a wide range of pharmacological activity, including neuroprotective, which was demonstrated in experimental modeling of various neurodegenerative diseases and pathological conditions of the brain. The neuroprotective effect of thymoquinone is largely due to its antioxidant ability. Currently available data show that thymoquinone is an effective means to reduce the negative consequences of acute and chronic forms of cerebral pathology, leading to the normalization of the content of antioxidant enzymes and preventing an increase in the level of lipid peroxidation products. Antioxidant properties make this substance a promising basis for the development of prototypes of therapeutic agents aimed at the treatment of a number of degenerative diseases of the central nervous system.
氧化应激是神经退行性过程中神经元损伤的主要致病因素之一;这使其成为神经保护剂作用应指向的重要治疗靶点。其中一种药物是百里醌。根据现代数据,这种物质具有广泛的药理活性,包括神经保护作用,这在各种神经退行性疾病和脑部病理状况的实验模型中得到了证实。百里醌的神经保护作用在很大程度上归因于其抗氧化能力。目前可得的数据表明,百里醌是减轻急性和慢性形式脑病理负面后果的有效手段,可使抗氧化酶含量恢复正常并防止脂质过氧化产物水平升高。抗氧化特性使该物质成为开发旨在治疗多种中枢神经系统退行性疾病的治疗剂原型的有前景的基础。